StockData
Advanced Biomed Inc. logo

Advanced Biomed Inc. (ADVB) stock

ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$2.10−0.12 (-5.41%)

Close on Nov 17, 2026Market cap $3.47MP/E 0.4Yield –

Advanced Biomed operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Advanced Biomed's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.95M. For fiscal 2026 it was -$1.95M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$1.95M–
FY2025Jun 30, 2025-$5.83M–
FY2024Jun 30, 2024-$2.13M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$583.27K–
Q3 FY2026CQ1 2026Mar 31, 2026-$239.78K–
Q2 FY2026CQ4 2025Dec 31, 2025-$513.56K–
Q1 FY2026CQ3 2025Sep 30, 2025-$610.34K–
Q4 FY2025CQ2 2025Jun 30, 2025-$1.54M–
Q3 FY2025CQ1 2025Mar 31, 2025-$3.41M–
Q2 FY2025CQ4 2024Dec 31, 2024-$841.84K–
Q1 FY2025CQ3 2024Sep 30, 2024-$29.68K–
Q4 FY2024CQ2 2024Jun 30, 2024-$475.83K–
Q3 FY2024CQ1 2024Mar 31, 2024-$1.07M–

More Advanced Biomed figures

See a number that looks wrong?